Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
The Pharma Letter
43m
Erleada shows clinically-meaningful improvement in prostate cancer OS
Johnson & Johnson today released results of a landmark real-world head-to-head study showing that Erleada (apalutamide) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Court filing made public
Helene's wake
Walz, Vance VP debate
Teacher wins pronouns case
MS-13 associate sentenced
NASCAR sued by Jordan
Repairman's claims rejected
Suspended five games
Factory probed after Helene
AR marijuana expansion suit
Starlink terminals to NC
Michel sues Hill for fraud
Historic ship reef plan
CA food chemicals ban
Blasts near Israeli Embassy
CO2 found on Pluto's moon
Sex offender registry ruling
Partners with UK banks
GA disaster declaration
November trial set
Man sentenced for cloning
Nintendo opens museum
Valuation reaches $157B
Labor board targets Apple
Israel sends more troops
Drop box ban lawsuit
AG appeals abortion ruling
AZ voter registration glitch
Related topics
Zydus
Food and Drug Administration
Johnson & Johnson
Erleada
USFDA
Feedback